Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan

• Yusuke Yasutomi ,

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: zikuzaku1114@gmail.com

  ¶¤ Medical Affairs, GSK, Tokyo, Japan

  Affiliation Medical Affairs, GSK, Tokyo, Japan

  https://orcid.org/0009-0000-1853-974X

  ⨯
• Masashi Takano,

  Roles Conceptualization, Supervision, Visualization, Writing – original draft, Writing – review & editing, Methodology

  Affiliation Real World Data Analytics, GSK, Tokyo, Japan

  ⨯
• Yi-Chen Chen,

  Roles Conceptualization, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing

  Affiliation Value Evidence & Outcomes APAC, GSK, Singapore, Singapore

  ⨯
• Chi-Chang Chen,

  Roles Formal analysis, Methodology, Software, Writing – review & editing

  Affiliation Real World Evidence Solutions, IQVIA, Wayne, United States of America

  ⨯
• Seok-Won Kim,

  Roles Formal analysis, Methodology, Project administration, Software, Visualization, Writing – review & editing

  Affiliation Real World Evidence Solutions, IQVIA, Tokyo, Japan

  https://orcid.org/0000-0002-9909-5649

  ⨯
• Catherine McGuiness,

  Roles Methodology, Software, Writing – review & editing, Formal analysis

  Affiliation Health Economics and Outcomes Research, Real World Evidence, IQVIA, Wayne, United States of America

  ⨯
• Alex Slowley,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing

  Affiliation Global Value Evidence and Outcomes (VEO), GSK, London, United Kingdom

  ⨯
• Keita Kirito

  Roles Methodology, Writing – review & editing

  Affiliation Department of Hematology/Oncology, University of Yamanashi, Yamanashi, Japan‌‌

  ⨯